Skip to main content

PETS

Stock
Health Care
Pharmaceutical Retailers

Performance overview

PETS Price
Price Chart

Forward-looking statistics

Beta
0.86
Risk
72.15%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.

Company info

SectorHealth Care
IndustryPharmaceutical Retailers
Employees221
Market cap$91.8M

Fundamentals

Enterprise value$19.5M
Revenue$247.0M
Revenue per employee
Profit margin0.14%
Debt to equity1.15

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$0.01
Dividend per share$1.20
Revenue per share$12.02
Avg trading volume (30 day)$392K
Avg trading volume (10 day)$389K
Put-call ratio

Macro factor sensitivity

Growth-6.5
Credit+10.9
Liquidity+3.8
Inflation-9.1
Commodities-2.6
Interest Rates-2.0

Valuation

Dividend yield36.25%
PEG Ratio-109.67
Price to sales0.28
P/E Ratio-109.67
Enterprise Value to Revenue0.08
Price to book0.71

Upcoming events

Next earnings dayNovember 7, 2024
Next dividend day
Ex. dividend dayAugust 11, 2023

News

Here's Why PetMed (PETS) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research (December 23, 2024)
Pets At Home Purrs As FY Profits Meet Updated Guidance

Pets at Home was one of the FTSE 250's best performers on Wednesday, as the retailer announced full-year results in line with January's downgraded guidance.

Forbes (May 29, 2024)
Stocks moving in after hours: Chegg, Petmed Express, Simon Property Group

Yahoo Finance Live's Jared Blikre checks out several stocks trending in the after-hours trading session.

Yahoo Finance (February 6, 2023)
PetMed Express Q3 Earnings Lag Street Forecasts, Posts Lower Profitability

PetMed Express Inc (NASDAQ: PETS) reported a Q3 EPS of $0.21, missing the consensus of $0.33 and lower than $0.38 posted a year ago. Net sales were $60.7 million, down 7.9% Y/Y and far below the consensus of $68.47 million.

Benzinga (January 25, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free